 | • レポートコード：MRC2Q12-19421 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、がん治療薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 がん治療薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 がん治療薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 がん治療薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのがん治療薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のがん治療薬の売上および2028年までの予測に焦点を当てています。 がん治療薬のグローバル主要企業には、Novartis AG、CELGENE CORPORATION、Merck & Company Inc、Pfizer Inc.、Johnson & Johnson、Roche、GlaxoSmithKline plc、AstraZeneca、Teva Pharmaceutical Industries Ltd、Takeda、Astellas、NATCO Pharma Limited、Amgen、Ipsen、Aurobindo Pharma、Hikma Pharmaceuticals PLC、Mylan、Sanofi、Bayer、Biogen Idecなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 がん治療薬市場は、タイプとアプリケーションによって区分されます。世界のがん治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 化学治療薬、分子標的治療薬、免疫治療薬、ホルモン治療薬、その他 【アプリケーション別セグメント】 血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - がん治療薬製品概要 - タイプ別市場（化学治療薬、分子標的治療薬、免疫治療薬、ホルモン治療薬、その他） - アプリケーション別市場（血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のがん治療薬販売量予測2017-2028 - 世界のがん治療薬売上予測2017-2028 - がん治療薬の地域別販売量 - がん治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別がん治療薬販売量 - 主要メーカー別がん治療薬売上 - 主要メーカー別がん治療薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（化学治療薬、分子標的治療薬、免疫治療薬、ホルモン治療薬、その他） - がん治療薬のタイプ別販売量 - がん治療薬のタイプ別売上 - がん治療薬のタイプ別価格 ・アプリケーション別市場規模（血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他） - がん治療薬のアプリケーション別販売量 - がん治療薬のアプリケーション別売上 - がん治療薬のアプリケーション別価格 ・北米市場 - 北米のがん治療薬市場規模（タイプ別、アプリケーション別） - 主要国別のがん治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのがん治療薬市場規模（タイプ別、アプリケーション別） - 主要国別のがん治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のがん治療薬市場規模（タイプ別、アプリケーション別） - 主要国別のがん治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のがん治療薬市場規模（タイプ別、アプリケーション別） - 主要国別のがん治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのがん治療薬市場規模（タイプ別、アプリケーション別） - 主要国別のがん治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Novartis AG、CELGENE CORPORATION、Merck & Company Inc、Pfizer Inc.、Johnson & Johnson、Roche、GlaxoSmithKline plc、AstraZeneca、Teva Pharmaceutical Industries Ltd、Takeda、Astellas、NATCO Pharma Limited、Amgen、Ipsen、Aurobindo Pharma、Hikma Pharmaceuticals PLC、Mylan、Sanofi、Bayer、Biogen Idec ・産業チェーン及び販売チャネル分析 - がん治療薬の産業チェーン分析 - がん治療薬の原材料 - がん治療薬の生産プロセス - がん治療薬の販売及びマーケティング - がん治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - がん治療薬の産業動向 - がん治療薬のマーケットドライバー - がん治療薬の課題 - がん治療薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Treat Oncology Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Treat Oncology Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Treat Oncology Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Treat Oncology Drug include Novartis AG, CELGENE CORPORATION, Merck & Company Inc, Pfizer Inc., Johnson & Johnson, Roche, GlaxoSmithKline plc, AstraZeneca and Teva Pharmaceutical Industries Ltd, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Treat Oncology Drug manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Treat Oncology Drug market. Further, it explains the major drivers and regional dynamics of the global Treat Oncology Drug market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Novartis AG
CELGENE CORPORATION
Merck & Company Inc
Pfizer Inc.
Johnson & Johnson
Roche
GlaxoSmithKline plc
AstraZeneca
Teva Pharmaceutical Industries Ltd
Takeda
Astellas
NATCO Pharma Limited
Amgen
Ipsen
Aurobindo Pharma
Hikma Pharmaceuticals PLC
Mylan
Sanofi
Bayer
Biogen Idec
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Treat Oncology Drug Segment by Type
Chemotherapy Drug
Targeted Therapy Drug
Immunotherapy Drug
Hormone Therapy Drug
Others
Treat Oncology Drug Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Lung Cancer
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Treat Oncology Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Treat Oncology Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Treat Oncology Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Treat Oncology Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Treat Oncology Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Treat Oncology Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Treat Oncology Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis AG, CELGENE CORPORATION, Merck & Company Inc, Pfizer Inc., Johnson & Johnson, Roche, GlaxoSmithKline plc, AstraZeneca and Teva Pharmaceutical Industries Ltd, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Treat Oncology Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Treat Oncology Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Treat Oncology Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Treat Oncology Drug Product Introduction
1.2 Market by Type
1.2.1 Global Treat Oncology Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy Drug
1.2.3 Targeted Therapy Drug
1.2.4 Immunotherapy Drug
1.2.5 Hormone Therapy Drug
1.2.6 Others
1.3 Market by Application
1.3.1 Global Treat Oncology Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Treat Oncology Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Treat Oncology Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Treat Oncology Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Treat Oncology Drug Sales by Region
2.4.1 Global Treat Oncology Drug Sales by Region (2017-2022)
2.4.2 Global Sales Treat Oncology Drug by Region (2023-2028)
2.5 Global Treat Oncology Drug Revenue by Region
2.5.1 Global Treat Oncology Drug Revenue by Region (2017-2022)
2.5.2 Global Treat Oncology Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Treat Oncology Drug Sales by Manufacturers
3.1.1 Global Top Treat Oncology Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Treat Oncology Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Treat Oncology Drug in 2021
3.2 Global Treat Oncology Drug Revenue by Manufacturers
3.2.1 Global Treat Oncology Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Treat Oncology Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Treat Oncology Drug Revenue in 2021
3.3 Global Treat Oncology Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Treat Oncology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Treat Oncology Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Treat Oncology Drug Sales by Type
4.1.1 Global Treat Oncology Drug Historical Sales by Type (2017-2022)
4.1.2 Global Treat Oncology Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Treat Oncology Drug Sales Market Share by Type (2017-2028)
4.2 Global Treat Oncology Drug Revenue by Type
4.2.1 Global Treat Oncology Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Treat Oncology Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Treat Oncology Drug Revenue Market Share by Type (2017-2028)
4.3 Global Treat Oncology Drug Price by Type
4.3.1 Global Treat Oncology Drug Price by Type (2017-2022)
4.3.2 Global Treat Oncology Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Treat Oncology Drug Sales by Application
5.1.1 Global Treat Oncology Drug Historical Sales by Application (2017-2022)
5.1.2 Global Treat Oncology Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Treat Oncology Drug Sales Market Share by Application (2017-2028)
5.2 Global Treat Oncology Drug Revenue by Application
5.2.1 Global Treat Oncology Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Treat Oncology Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Treat Oncology Drug Revenue Market Share by Application (2017-2028)
5.3 Global Treat Oncology Drug Price by Application
5.3.1 Global Treat Oncology Drug Price by Application (2017-2022)
5.3.2 Global Treat Oncology Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Treat Oncology Drug Market Size by Type
6.1.1 North America Treat Oncology Drug Sales by Type (2017-2028)
6.1.2 North America Treat Oncology Drug Revenue by Type (2017-2028)
6.2 North America Treat Oncology Drug Market Size by Application
6.2.1 North America Treat Oncology Drug Sales by Application (2017-2028)
6.2.2 North America Treat Oncology Drug Revenue by Application (2017-2028)
6.3 North America Treat Oncology Drug Market Size by Country
6.3.1 North America Treat Oncology Drug Sales by Country (2017-2028)
6.3.2 North America Treat Oncology Drug Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Treat Oncology Drug Market Size by Type
7.1.1 Europe Treat Oncology Drug Sales by Type (2017-2028)
7.1.2 Europe Treat Oncology Drug Revenue by Type (2017-2028)
7.2 Europe Treat Oncology Drug Market Size by Application
7.2.1 Europe Treat Oncology Drug Sales by Application (2017-2028)
7.2.2 Europe Treat Oncology Drug Revenue by Application (2017-2028)
7.3 Europe Treat Oncology Drug Market Size by Country
7.3.1 Europe Treat Oncology Drug Sales by Country (2017-2028)
7.3.2 Europe Treat Oncology Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Treat Oncology Drug Market Size by Type
8.1.1 Asia Pacific Treat Oncology Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Treat Oncology Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Treat Oncology Drug Market Size by Application
8.2.1 Asia Pacific Treat Oncology Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Treat Oncology Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Treat Oncology Drug Market Size by Region
8.3.1 Asia Pacific Treat Oncology Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Treat Oncology Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Treat Oncology Drug Market Size by Type
9.1.1 Latin America Treat Oncology Drug Sales by Type (2017-2028)
9.1.2 Latin America Treat Oncology Drug Revenue by Type (2017-2028)
9.2 Latin America Treat Oncology Drug Market Size by Application
9.2.1 Latin America Treat Oncology Drug Sales by Application (2017-2028)
9.2.2 Latin America Treat Oncology Drug Revenue by Application (2017-2028)
9.3 Latin America Treat Oncology Drug Market Size by Country
9.3.1 Latin America Treat Oncology Drug Sales by Country (2017-2028)
9.3.2 Latin America Treat Oncology Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Treat Oncology Drug Market Size by Type
10.1.1 Middle East and Africa Treat Oncology Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Treat Oncology Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Treat Oncology Drug Market Size by Application
10.2.1 Middle East and Africa Treat Oncology Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Treat Oncology Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Treat Oncology Drug Market Size by Country
10.3.1 Middle East and Africa Treat Oncology Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Treat Oncology Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Overview
11.1.3 Novartis AG Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis AG Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis AG Recent Developments
11.2 CELGENE CORPORATION
11.2.1 CELGENE CORPORATION Corporation Information
11.2.2 CELGENE CORPORATION Overview
11.2.3 CELGENE CORPORATION Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CELGENE CORPORATION Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CELGENE CORPORATION Recent Developments
11.3 Merck & Company Inc
11.3.1 Merck & Company Inc Corporation Information
11.3.2 Merck & Company Inc Overview
11.3.3 Merck & Company Inc Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck & Company Inc Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck & Company Inc Recent Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Corporation Information
11.4.2 Pfizer Inc. Overview
11.4.3 Pfizer Inc. Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Inc. Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Inc. Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Overview
11.6.3 Roche Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Roche Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Roche Recent Developments
11.7 GlaxoSmithKline plc
11.7.1 GlaxoSmithKline plc Corporation Information
11.7.2 GlaxoSmithKline plc Overview
11.7.3 GlaxoSmithKline plc Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GlaxoSmithKline plc Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GlaxoSmithKline plc Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AstraZeneca Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Teva Pharmaceutical Industries Ltd
11.9.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.9.2 Teva Pharmaceutical Industries Ltd Overview
11.9.3 Teva Pharmaceutical Industries Ltd Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Teva Pharmaceutical Industries Ltd Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.10 Takeda
11.10.1 Takeda Corporation Information
11.10.2 Takeda Overview
11.10.3 Takeda Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takeda Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takeda Recent Developments
11.11 Astellas
11.11.1 Astellas Corporation Information
11.11.2 Astellas Overview
11.11.3 Astellas Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Astellas Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Astellas Recent Developments
11.12 NATCO Pharma Limited
11.12.1 NATCO Pharma Limited Corporation Information
11.12.2 NATCO Pharma Limited Overview
11.12.3 NATCO Pharma Limited Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 NATCO Pharma Limited Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 NATCO Pharma Limited Recent Developments
11.13 Amgen
11.13.1 Amgen Corporation Information
11.13.2 Amgen Overview
11.13.3 Amgen Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Amgen Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Amgen Recent Developments
11.14 Ipsen
11.14.1 Ipsen Corporation Information
11.14.2 Ipsen Overview
11.14.3 Ipsen Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Ipsen Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Ipsen Recent Developments
11.15 Aurobindo Pharma
11.15.1 Aurobindo Pharma Corporation Information
11.15.2 Aurobindo Pharma Overview
11.15.3 Aurobindo Pharma Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Aurobindo Pharma Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Aurobindo Pharma Recent Developments
11.16 Hikma Pharmaceuticals PLC
11.16.1 Hikma Pharmaceuticals PLC Corporation Information
11.16.2 Hikma Pharmaceuticals PLC Overview
11.16.3 Hikma Pharmaceuticals PLC Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Hikma Pharmaceuticals PLC Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Hikma Pharmaceuticals PLC Recent Developments
11.17 Mylan
11.17.1 Mylan Corporation Information
11.17.2 Mylan Overview
11.17.3 Mylan Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Mylan Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Mylan Recent Developments
11.18 Sanofi
11.18.1 Sanofi Corporation Information
11.18.2 Sanofi Overview
11.18.3 Sanofi Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Sanofi Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Sanofi Recent Developments
11.19 Bayer
11.19.1 Bayer Corporation Information
11.19.2 Bayer Overview
11.19.3 Bayer Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Bayer Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Bayer Recent Developments
11.20 Biogen Idec
11.20.1 Biogen Idec Corporation Information
11.20.2 Biogen Idec Overview
11.20.3 Biogen Idec Treat Oncology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Biogen Idec Treat Oncology Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Biogen Idec Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Treat Oncology Drug Industry Chain Analysis
12.2 Treat Oncology Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Treat Oncology Drug Production Mode & Process
12.4 Treat Oncology Drug Sales and Marketing
12.4.1 Treat Oncology Drug Sales Channels
12.4.2 Treat Oncology Drug Distributors
12.5 Treat Oncology Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Treat Oncology Drug Industry Trends
13.2 Treat Oncology Drug Market Drivers
13.3 Treat Oncology Drug Market Challenges
13.4 Treat Oncology Drug Market Restraints
14 Key Findings in The Global Treat Oncology Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer